BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Queensland Health
AstraZeneca
Johnson and Johnson
Mallinckrodt
UBS
Fuji
Deloitte
Moodys

Generated: January 21, 2018

DrugPatentWatch Database Preview

Sun Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?

SUN PHARM INDS has two hundred and seventeen approved drugs.

There are thirteen US patents protecting SUN PHARM INDS drugs and there have been two Paragraph IV challenges on SUN PHARM INDS drugs in the past three years. There are four tentative approvals on SUN PHARM INDS drugs.

There are forty-one patent family members on SUN PHARM INDS drugs in twenty-three countries and one hundred and fifty-seven supplementary protection certificates in thirteen countries.

Summary for Sun Pharm Inds
International Patents:41
US Patents:13
Tradenames:161
Ingredients:150
NDAs:217

Drugs and US Patents for Sun Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc INDOMETHACIN indomethacin CAPSULE;ORAL 091401-002 Mar 28, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 074644-002 Dec 10, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd NEFAZODONE HYDROCHLORIDE nefazodone hydrochloride TABLET;ORAL 076409-001 Sep 16, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 087083-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-002 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 077631-003 Jan 11, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078627-004 Jun 13, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091200-003 Dec 13, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 077828-001 Aug 23, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 040816-005 Jun 27, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Sun Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd ULTRAVATE halobetasol propionate CREAM;TOPICAL 019967-001 Dec 27, 1990 ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc EXELDERM sulconazole nitrate SOLUTION;TOPICAL 018738-001 Aug 30, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 25 mg ➤ Subscribe 5/16/2016
➤ Subscribe Capsules 35 mg ➤ Subscribe 11/25/2015
➤ Subscribe Capsules 20 mg ➤ Subscribe 6/19/2013
➤ Subscribe Capsules 20 mg ➤ Subscribe 1/7/2013
➤ Subscribe Capsules 30 mg and 40 mg ➤ Subscribe 12/31/2012

Non-Orange Book US Patents for Sun Pharm Inds

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,559,187 Liquid formulation of metformin ➤ Subscribe
8,722,650 Extended-release minocycline dosage forms ➤ Subscribe
9,192,615 Method for the treatment of acne and certain dosage forms thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Sun Pharm Inds Drugs

Supplementary Protection Certificates for Sun Pharm Inds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00053 Denmark ➤ Subscribe PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1998 Austria ➤ Subscribe PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214
C0008 Belgium ➤ Subscribe PRODUCT NAME: FOSPHENYTOINUM DINATRICUM; REGISTRATION NO/DATE: 19 IS 102 F12 19980901; FIRST REGISTRATION: GB PL00019/1057 19980204
0625 Netherlands ➤ Subscribe PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414
C0038 France ➤ Subscribe PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
12/018 Ireland ➤ Subscribe PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705
C0048 France ➤ Subscribe PRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707
C0028 France ➤ Subscribe PRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124
C/GB98/022 United Kingdom ➤ Subscribe PRODUCT NAME: TIAGABINE ( INCLUDING SALTS THEREOF ); REGISTERED: FR AMM NO. 341 260.2 19960614; FR AMM NO. 341 262.5 19960614; FR AMM NO. 341 264.8 19960614; UK 03132/0117 19971111; UK 03132/0118 19971111; UK 03132/0119 19971111
C0008 Belgium ➤ Subscribe PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Accenture
Healthtrust
Teva
Argus Health
Chubb
Federal Trade Commission
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot